11/19
04:21 pm
mrkr
Form 4 Marker Therapeutics, For: Nov 17 Filed by: Knobil Katharine
Medium
Report
Form 4 Marker Therapeutics, For: Nov 17 Filed by: Knobil Katharine
11/19
04:10 pm
mrkr
Form 4 Marker Therapeutics, For: Nov 17 Filed by: Eansor Norman David
Medium
Report
Form 4 Marker Therapeutics, For: Nov 17 Filed by: Eansor Norman David
11/19
04:01 pm
mrkr
Form 4 Marker Therapeutics, For: Nov 17 Filed by: ELMS STEVE
Medium
Report
Form 4 Marker Therapeutics, For: Nov 17 Filed by: ELMS STEVE
11/17
04:23 pm
mrkr
Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Medium
Report
Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
11/14
08:09 pm
mrkr
Form SCHEDULE 13G/A Marker Therapeutics, Filed by: Alyeska Investment Group, L.P.
Low
Report
Form SCHEDULE 13G/A Marker Therapeutics, Filed by: Alyeska Investment Group, L.P.
11/14
07:21 am
mrkr
Form 8-K Marker Therapeutics, For: Nov 14
Medium
Report
Form 8-K Marker Therapeutics, For: Nov 14
11/5
07:37 am
mrkr
Form 8-K Marker Therapeutics, For: Oct 31
Low
Report
Form 8-K Marker Therapeutics, For: Oct 31
11/4
05:09 pm
mrkr
Form 4 Marker Therapeutics, For: Oct 31 Filed by: Corzo Kathryn Penkus
Low
Report
Form 4 Marker Therapeutics, For: Oct 31 Filed by: Corzo Kathryn Penkus
11/4
05:03 pm
mrkr
Form 4 Marker Therapeutics, For: Oct 31 Filed by: Vera Juan
Low
Report
Form 4 Marker Therapeutics, For: Oct 31 Filed by: Vera Juan
11/4
04:55 pm
mrkr
Form 3 Marker Therapeutics, For: Oct 31 Filed by: Corzo Kathryn Penkus
Low
Report
Form 3 Marker Therapeutics, For: Oct 31 Filed by: Corzo Kathryn Penkus
10/6
07:31 am
mrkr
Form 8-K Marker Therapeutics, For: Oct 06
Medium
Report
Form 8-K Marker Therapeutics, For: Oct 06